This brain penetrant, biologically active metabolite of pioglitazone, increases frataxin levels and ameliorates cell death in mouse dorsal root ganglion cell models of FRDA; it also improves altered motor function in one mouse FRDA model. This evidence concerns the gene FXN and Friedreich ataxia.